Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Cboe UK GBp

Halma plc (HLMAL.XC)

Compare
2,920.00
-10.00
(-0.34%)
At close: February 21 at 4:29:40 PM GMT
Loading Chart for HLMAL.XC
DELL
  • Previous Close 2,930.00
  • Open 2,942.00
  • Bid 2,920.00 x --
  • Ask 2,922.00 x --
  • Day's Range 2,913.00 - 2,951.00
  • 52 Week Range 2,142.50 - 3,094.00
  • Volume 88,948
  • Avg. Volume 117,051
  • Market Cap (intraday) 11.067B
  • Beta (5Y Monthly) 0.58
  • PE Ratio (TTM) 3,842.11
  • EPS (TTM) 0.76
  • Earnings Date --
  • Forward Dividend & Yield 0.22 (0.76%)
  • Ex-Dividend Date Dec 19, 2024
  • 1y Target Est --

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.

www.halma.com

8,000

Full Time Employees

March 31

Fiscal Year Ends

Recent News: HLMAL.XC

View More

Performance Overview: HLMAL.XC

Trailing total returns as of 2/21/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

HLMAL.XC
8.23%
FTSE 100
5.95%

1-Year Return

HLMAL.XC
27.78%
FTSE 100
13.01%

3-Year Return

HLMAL.XC
33.83%
FTSE 100
15.70%

5-Year Return

HLMAL.XC
36.62%
FTSE 100
16.96%

Compare To: HLMAL.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HLMAL.XC

View More

Valuation Measures

Annual
As of 2/21/2025
  • Market Cap

    10.99B

  • Enterprise Value

    11.64B

  • Trailing P/E

    38.61

  • Forward P/E

    29.94

  • PEG Ratio (5yr expected)

    3.61

  • Price/Sales (ttm)

    5.12

  • Price/Book (mrq)

    6.33

  • Enterprise Value/Revenue

    5.39

  • Enterprise Value/EBITDA

    22.89

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.28%

  • Return on Assets (ttm)

    8.72%

  • Return on Equity (ttm)

    16.90%

  • Revenue (ttm)

    2.16B

  • Net Income Avi to Common (ttm)

    286.5M

  • Diluted EPS (ttm)

    0.76

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    180.2M

  • Total Debt/Equity (mrq)

    47.51%

  • Levered Free Cash Flow (ttm)

    302.09M

Research Analysis: HLMAL.XC

View More

Company Insights: HLMAL.XC

Research Reports: HLMAL.XC

View More

People Also Watch